Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Employer
-
Field
-
the USA. Details about our research can be found on the departmental website http://www.ucl.ac.uk/chemistry Applications are invited for a Postdoctoral Research Associate to work in the group of Dr Yang
-
the project lead if you have further questions about the project. For more information and how to apply: https://www.jobbnorge.no/en/available-jobs/job/293031/postdoctoral-research-fellow-in-studying-the-role
-
. The results are to be generated in a suitable format for modelling in radio systems. Where to apply Website https://www.timeshighereducation.com/unijobs/listing/406239/postdoctoral-resear… Requirements
-
for Cancer Biology: https://www.vibcancer.be VIB Center for AI and Computational Biology: https://vib.ai/ For questions: jonas.demeulemeester@kuleuven.be KU Leuven and VIB aim to be inclusive, respectful and
-
). For a full job description please visit UCL’s online recruitment portal (https://www.ucl.ac.uk/work-at-ucl/search-ucl-jobs ) and search using vacancy reference B02-09795. To apply, please upload a current
-
8 Dec 2025 Job Information Organisation/Company Université Catholique de Louvain (UCL) Department ICTEAM Research Field Computer science » Computer systems Researcher Profile Recognised Researcher
-
About the role: Applications are invited for a 4-year postdoctoral research position to work collaboratively between the teams of Alexis Barr (MRC LMS) and Maria Secrier (Dept. of Genetics, UCL). We
-
, through the FNRS "Postdoctoral researcher - CR" programme (with deadline on 20 January 2026, results in June 2026, and starting date in October 2026, here ) at the university level, through the FSR
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and